ITGAM and thyroid cancer: The mouse thyroid cancer model used in this study recapitulates the inflammatory nature of aggressive BRAFV600E thyroid cancer with the massive recruitment of immunosuppressive macrophages expressing typical M2-like markers, such as CD206, F4/80, CD11b and Stab1 [61].